Jacob G. Scott (he/him)
Jacob G. Scott (he/him)
Associate Professor and Staff Physician-Scientist, Translational Hematology and Oncology Research
Verified email at - Homepage
Cited by
Cited by
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
JG Scott, A Berglund, MJ Schell, I Mihaylov, WJ Fulp, B Yue, E Welsh, ...
The Lancet Oncology, 2017
Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches
M Zhou, J Scott, B Chaudhury, L Hall, D Goldgof, KW Yeom, M Iv, Y Ou, ...
American Journal of Neuroradiology 39 (2), 208-216, 2018
Whole brain radiotherapy for brain metastasis
E McTyre, J Scott, P Chinnaiyan
Surgical neurology international 4 (Suppl 4), S236, 2013
The 2019 mathematical oncology roadmap
RC Rockne, A Hawkins-Daarud, KR Swanson, JP Sluka, JA Glazier, ...
Physical biology 16 (4), 041005, 2019
Steering evolution with sequential therapy to prevent the emergence of bacterial antibiotic resistance
D Nichol, P Jeavons, AG Fletcher, RA Bonomo, PK Maini, JL Paul, ...
PLoS computational biology 11 (9), e1004493, 2015
Antibiotic collateral sensitivity is contingent on the repeatability of evolution
D Nichol, J Rutter, C Bryant, AM Hujer, S Lek, MD Adams, P Jeavons, ...
Nature communications 10 (1), 334, 2019
Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer
A Kaznatcheev, J Peacock, D Basanta, A Marusyk, JG Scott
Nature ecology & evolution 3 (3), 450, 2019
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older
JG Scott, L Bauchet, TJ Fraum, L Nayak, AR Cooper, ST Chao, JH Suh, ...
Cancer 118 (22), 5595-5600, 2012
Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors
A Dhawan, JG Scott, AL Harris, FM Buffa
Nature communications 9 (1), 5228, 2018
The Damaging Effect of Passenger Mutations on Cancer Progression
CD McFarland, JA Yaglom, JW Wojtkowiak, JG Scott, DL Morse, ...
Cancer research 77 (18), 4763-4772, 2017
Effectiveness of radiotherapy for elderly patients with glioblastoma
J Scott, YY Tsai, P Chinnaiyan, HHM Yu
International Journal of Radiation Oncology* Biology* Physics 81 (1), 206-210, 2011
The effects of modified posterior tibial slope on anterior cruciate ligament strain and knee kinematics–a human cadaveric study
SD Fening, J Kovacic, H Kambic, S McLean, J Scott, A Miniaci
The journal of knee surgery 21 (03), 205-211, 2008
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases
JG Scott, JH Suh, P Elson, GH Barnett, MA Vogelbaum, DM Peereboom, ...
Neuro-oncology 13 (4), 428-436, 2011
Investigating prostate cancer tumour–stroma interactions: clinical and biological insights from an evolutionary game
D Basanta, JG Scott, MN Fishman, G Ayala, SW Hayward, ARA Anderson
British journal of cancer 106 (1), 174-181, 2012
UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemic
DT Weaver, BD McElvany, V Gopalakrishnan, KJ Card, D Crozier, ...
PLoS One 16 (7), e0241734, 2021
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis
JG Scott, G Sedor, P Ellsworth, JA Scarborough, KA Ahmed, DE Oliver, ...
The Lancet Oncology 22 (9), 1221-1229, 2021
Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status
AL Baldock, K Yagle, DE Born, S Ahn, AD Trister, M Neal, SK Johnston, ...
Neuro-oncology 16 (6), 779-786, 2014
Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer
A Dhawan, D Nichol, F Kinose, ME Abazeed, A Marusyk, EB Haura, ...
Scientific reports 7 (1), 1232, 2017
Controlling the speed and trajectory of evolution with counterdiabatic driving
S Iram, E Dolson, J Chiel, J Pelesko, N Krishnan, Ö Güngör, ...
Nature Physics 17 (1), 135-142, 2021
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures
R Vander Velde, N Yoon, V Marusyk, A Durmaz, A Dhawan, ...
Nature communications 11 (1), 2393, 2020
The system can't perform the operation now. Try again later.
Articles 1–20